Anecortave Acetate Reduces Ocular Hypertension

Ophthalmology Times

In eyes with uncontrolled steroid-related ocular hypertension, treatment with anecortave acetate results in a safe and rapid reduction of hypertension that persists for up to six months or more, according to the results of a small study published in the February issue of the Archives of Ophthalmology.